Rheumatology

EULAR COVID-19 Recommendations Say Continue Medications, but Vaccinate

June 09, 2020

EULAR has issued treatment recommendations for patients with rheumatic and musculoskeletal conditions with SARS-CoV-2 or COVID-19. A task force of 20 physicians settled on five overarching principles and 13 recommendations, which are similar to COVID-19 treatment guidelines issued by ACR in April-with slight variations.

EULAR 2020 Roundup: Men Get Sjogren's Too

June 09, 2020

In this slideshow, we highlight some presentations from EULAR 2020 we thought would interest you. The list includes a study that shows primary Sjogren’s syndrome affects men as well, and it highlights findings from a study that shows voclosporin was effective in treating lupus neprhitis in Latinas, a group disproportionately affected by the condition. More in this slideshow.

EULAR Report: Dual Cause of Increased CV Risk in Ankylosing Spondylitis Needs Attention

June 08, 2020

The increased cardiovascular disease risk in patients with ankylosing spondylitis is explained both by traditional  cardiovascular risk factors as well as the underlying chronic inflammatory process. However, this dual etiology is not adequately addressed in clinical practice, according to a presentation on June 3 at the European Congress of Rheumatology (EULAR) annual meeting.

EULAR Report: Cesarean Deliveries Higher in Spondyloarthritis

June 08, 2020

Spondyloarthritis is associated with an increased risk of preterm births, small gestational age infants and elective cesarean section deliveries, according to study data presented on June 4 at the European Congress of Rheumatology (EULAR) annual meeting.

Opioid Use on the Rise in Europe

June 05, 2020

German researchers reported at EULAR this week that patients with rheumatic and musculoskeletal-related pain are increasingly turning to opioids and continue to take them even after the pain subsides.

COVID-19 and Rheumatic Disease Findings Reported at EULAR

June 05, 2020

COVID-19 was center-stage at this year's EULAR meeting. Dr. Pedro Machado, a rheumatologist with the University College London and chair of EULAR's Standing Committee for Epidemiology and Health Service Research shared the results of a study on patients with rheumatic disease who contracted COVID-19. He and his team found that patients taking a higher dose of prednisone, had an increased of being hospitalized. But patients receiving TNF blockers were less likely to be hospitalized. In this interview, Dr. Machado talks with us about the findings.

EULAR Report: Ixekizumab Approved for Axial Spondyloarthritis

June 04, 2020

Eli Lilly announced this week that Taltz (ixekizumab) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA). And, this week during the EULAR annual meeting, the company is reporting results from the 52-week SPIRIT phase 3b/4 trial for psoriatic arthritis comparing ixekizumab to adalimumab.

EULAR Report: Steroid Use Linked to More Severe COVID-19 Cases

June 04, 2020

Rheumatic disease patients treated with anti-TNF therapy and who contracted COVID-19, were hospitalized less often than patients treated with glucocorticoids, shows an observational study presented on Wednesday at the European Congress of Rheumatology (EULAR) annual meeting-which is being held virtually this week from the homes of more than 18,000 registered attendees.

Rheumatoid Arthritis and Cardiovascular Disease Share Etiology

June 02, 2020

Researchers writing in Arthritis and Rheumatology report that high levels of anti-citrullinated protein antibodies (anti-CCP2) appear to be markers for future cardiovascular events in rheumatoid arthritis patients.

Quiz: Best Practices for Corticosteroid Use in Active Rheumatoid Arthritis

June 01, 2020

Glucocorticoids are the most frequently used class of drugs for rheumatoid arthritis because they are effective at relieving symptoms, and widely available at low cost. While this drug class has clear benefits for rheumatoid arthritis, it comes at a price in terms of a wide array of potential side-effects. Test your knowledge on the use of corticosteroids in rheumatoid arthritis with this quiz.

x